# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TD Cowen analyst Joseph Giordano maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $135 to $138.
Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $147 to $152.
Xylem's long-term financial framework anticipates annual organic revenue growth in the range of 4 percent to 6 percent, wit...
Argus Research analyst John Eade maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $146 to $165.
RBC Capital analyst Deane Dray maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $157 to $162.
Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $142 to $147.